Vaxcyte, Inc.
PCVX
Revenue
0.00
0.000.00%
-Assets
2.09B
▼-4.04M▼-0.1931%
3 Months ChangeLiabilities
101.14M
▼-6.19M▼-5.76%
3 Months ChangeFree Cash Flow
-164.80M
▼-111.50M▼-209.20%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-06
Form 8-K
ID: 0001193125-24-214711
2024-09-03
Form 8-K
ID: 0001193125-24-211572
2024-08-06
Form 10-Q
ID: 0001649094-24-000052
2024-08-06
Form 8-K
ID: 0001649094-24-000051
2024-07-02
Form 8-K
ID: 0001193125-24-174317
2024-06-10
Form 8-K
ID: 0001193125-24-158355
2024-05-08
Form 10-Q
ID: 0001628280-24-021677
2024-05-08
Form 8-K
ID: 0001628280-24-021665
2024-02-27
Form 8-K
ID: 0000950170-24-021081
2024-01-31
Form 8-K
ID: 0001193125-24-021084